Vendor profile
UCB Pharma GmbH
DE- Awards
- 9
- Total awarded value
- €2,652,001
- Countries
- Germany
- Latest award
- Mar 2, 2026
- Expiring within 12 months
- 6
Award history
| Date | Buyer | Title | Category | Value | Country | Expires | Source |
|---|---|---|---|---|---|---|---|
| 03/02/2026 | PBMG eG | Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2026 und 01.07.2026 | Pharmaceuticals | €0.0 | DE | 12/31/2026 | View on TED ↗ |
| 03/02/2026 | PBMG eG | Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2026 und 01.07.2026 | Pharmaceuticals | €0.0 | DE | 12/31/2026 | View on TED ↗ |
| 03/02/2026 | PBMG eG | Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2026 und 01.07.2026 | — | €0.0 | DE | 12/31/2026 | View on TED ↗ |
| 11/28/2025 | AOK Baden-Württemberg | Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) | — | €2.2M | DE | 12/31/2025 | View on TED ↗ |
| 06/26/2025 | AOK Baden-Württemberg | Germany – Pharmaceutical products – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m. § 130a Abs. 8 SGB V zum Wirkstoff Romosozumab | — | €221.0K | DE | 06/30/2027 | View on TED ↗ |
| 04/15/2025 | PBMG eG | Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025 | — | — | DE | 12/31/2025 | View on TED ↗ |
| 12/23/2024 | AOK Baden-Württemberg | Germany – Pharmaceutical products – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zum Wirkstoff Bimekizumab | — | €221.0K | DE | 12/31/2026 | View on TED ↗ |
| 08/09/2024 | GWQ ServicePlus AG | Germany – Pharmaceutical products – 31. Generikaausschreibung (1b) Auftragsvergabe | — | — | DE | 12/31/2026 | View on TED ↗ |
| 03/25/2024 | PBMG eG | Germany – Pharmaceutical products – Arzneimittelvergaben zum 1.Januar 2024 | — | €1.0 | DE | 12/31/2024 | View on TED ↗ |